Measles Has Economic Consequences
Ongoing outbreaks of measles in the United States will lead to significant economic repercussions. Efforts in various countries to eliminate measles are partly motivated by the clear financial advantages of halting domestic virus transmission.
Research indicates that the cost to manage measles outbreaks can reach tens of thousands of dollars per case. For instance, a small outbreak in Washington state between 2018 and 2019, which involved just 72 cases, incurred around US$3.2 million for the public health response, medical costs, and productivity losses. The Common Health Coalition also noted that even a sustained 1 percent decline in MMR vaccinations could cost the US billions in health care and economic impacts.
A Gateway for Infectious Diseases
The recent outbreaks of measles are alarming, but they also point to a much deeper issue.
How a nation manages measles can serve as an indicator of its ability to tackle a variety of diseases. This is mainly because the strategies to curb transmission are similar: vaccinating to prevent infections, detecting and isolating cases as they arise, identifying those in contact with infected individuals, and ensuring they remain at home if they might be contagious.
Moreover, we’ve seen a resurgence of other diseases that were previously under control, like whooping cough, which saw a sharp increase in 2024 and continued to remain high in 2025 compared to the period before the COVID-19 pandemic.
This uptick relates closely to the public’s trust in vital public health measures. A drop in MMR vaccine uptake reflects broader issues with public support for vaccinations. Polling conducted between 2023 and early 2026 by KFF shows a decline in confidence in the current Centers for Disease Control and Prevention. Less than half of those surveyed expressed even a moderate level of trust in the government to provide reliable vaccine information.
These widening rifts in the country’s public health infrastructure will make it more challenging to shield Americans from future health threats—whether they come from an outbreak, a pandemic, or a biological attack.
